Formation and contraction of a microfilamentous shell in saponin-permeabilized platelets.
To study the mechanism of granule centralization in platelets, we permeabilized with saponin in either EGTA (5 mM) or calcium (1 or 10 microM). Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant. Thin sections of platelets permeabilized in EGTA showed a microfilament network under the residual plasma membrane and throughout the cytoplasm. Platelets permeabilized in calcium contained a microfilament shell partly separated from the residual membrane. The shell stained brightly for F-actin. A less dense microfilament shell was also seen in sections of ADP-stimulated intact platelets subsequently permeabilized in EGTA. In the presence of 1 mM ATP gamma S and calcium, myosin was retained (70%) and was localized by indirect immunofluorescence in bright central spots that also stained intensely for F-actin. Electron micrographs showed centralized granules surrounded by a closely packed mass of microfilaments much like the structures seen in thrombin-stimulated intact platelets subsequently permeabilized in EGTA. Permeabilization in calcium, ATP, and okadaic acid, produced the same configuration of centralized granules and packed microfilaments; myosin was retained and the myosin regulatory light chain became phosphorylated. Microtubule coil disassembly before permeabilization did not inhibit granule centralization. These results suggest a possible mechanism for granule centralization in these models. The cytoskeletal network first separates from some of its connections to the plasma membrane by a calcium-dependent mechanism not involving ABP proteolysis. Phosphorylated myosin interacts with the microfilaments to contract the shell moving the granules to the platelet's center.
Stark
F
F
Department of Anatomy, University of Pennsylvania School of Medicine, Philadelphia 19104-6058.
Golla
R
R
Nachmias
V T
VT
D008841:Actin Cytoskeleton / Q000737:chemistry / Q000648:ultrastructure*; D000199:Actins / Q000032:analysis; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D001792:Blood Platelets / Q000737:chemistry / Q000648:ultrastructure*; D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000032:analysis; D002458:Cell Fractionation; D003594:Cytoplasmic Granules / Q000648:ultrastructure*; D003598:Cytoskeletal Proteins / Q000032:analysis; D004533:Egtazic Acid; D004988:Ethers, Cyclic / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006801:Humans; D008840:Microfilament Proteins / Q000032:analysis / Q000378:metabolism; D008854:Microscopy, Electron; D009218:Myosins / Q000032:analysis / Q000378:metabolism; D019319:Okadaic Acid; D010539:Permeability; D012503:Saponins / Q000494:pharmacology; D016608:Talin
D000199:Actins; D001798:Blood Proteins; D003598:Cytoskeletal Proteins; D004988:Ethers, Cyclic; D008840:Microfilament Proteins; D012503:Saponins; D016608:Talin; D019319:Okadaic Acid; C022571:adenosine 5'-O-(3-thiotriphosphate); D004533:Egtazic Acid; D000255:Adenosine Triphosphate; D009218:Myosins; D002118:Calcium